Compare Inovio Pharmaceuticals Inc (INO) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Inovio Pharmaceuticals Inc trades at $1.09 (market cap $89.27M), while Invesco WilderHill Clean Energy ETF trades at $34.25. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | PBW | |
|---|---|---|
Market Cap | $89.27M | — |
Sector | Health | Sector/Thematic |
52-Week High | $2.87 | $46.99 |
52-Week Low | $1.05 | $22.23 |
Enterprise Value | $60.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.07, down 4.46% today, reflecting persistent bearish technical signals. The company shows minimal revenue of $65.34K (2025) with a net loss of $84.95M, resulting in a negative net margin of 130,000%. Despite beating recent EPS estimates, cash flow remains negative. Key near-term catalyst is the FDA's PDUFA decision on INO-3107 by October 30, 2026.
Outlook hinges on regulatory success for INO-3107; approval could drive significant upside, but failure poses substantial risk. High cash burn and lack of profitability underscore speculative nature. Analyst consensus is cautiously optimistic with 53% buy ratings, yet financial health remains precarious without near-term revenue growth.
PBW trades at $33.21, down 0.54% today, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The ETF faces volatility tied to interest rate cycles, with recent news highlighting clean energy sector tailwinds from energy security concerns and data center demand. Key financial ratios are unavailable, limiting fundamental assessment.
Outlook hinges on clean energy policy support and interest rate sensitivity, with risks including sector volatility and competitive ETF performance. The bearish technical stance and rate-driven sell-offs underscore caution, though long-term energy transition trends offer potential upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
